Casdin Capital, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2020$13,864,000
-14.3%
3,365,0000.0%1.47%
-1.1%
Q4 2019$16,186,000
-99.9%
3,365,0000.0%1.49%
-29.5%
Q3 2019$20,391,900,000
-6.6%
3,365,0000.0%2.11%
+3.2%
Q2 2019$21,838,850,000
+91436.8%
3,365,0000.0%2.04%
-22.0%
Q1 2019$23,858,000
+28.7%
3,365,000
-11.8%
2.62%
-17.4%
Q4 2018$18,541,000
-27.9%
3,815,000
+9.0%
3.17%
+1.4%
Q3 2018$25,725,000
+18.6%
3,500,000
+2.9%
3.13%
+3.1%
Q2 2018$21,692,000
+3.6%
3,400,000
-11.7%
3.03%
-17.6%
Q1 2018$20,944,000
+84.0%
3,850,000
+41.0%
3.68%
+32.9%
Q4 2017$11,384,000
-21.2%
2,730,000
+82.0%
2.77%
-32.0%
Q3 2017$14,445,000
+78.2%
1,500,000
+119.0%
4.08%
+36.1%
Q2 2017$8,104,000
+58.0%
685,000
+71.2%
3.00%
-0.9%
Q1 2017$5,128,000
-17.8%
400,000
-21.6%
3.02%
-41.3%
Q4 2016$6,242,000
-15.4%
510,000
-18.4%
5.16%
-13.7%
Q3 2016$7,375,000
+104.2%
625,000
+50.6%
5.97%
+66.2%
Q2 2016$3,611,000
+50.1%
415,000
+33.9%
3.59%
+69.0%
Q4 2015$2,406,000310,0002.13%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 2,730,000$11,384,0002.77%
CADIAN CAPITAL MANAGEMENT, LP 5,017,483$20,923,0001.28%
Ghost Tree Capital, LLC 500,000$2,085,0000.49%
Bellevue Group AG 773,677$3,226,0000.34%
NEEDHAM INVESTMENT MANAGEMENT LLC 180,000$750,0000.20%
Penn Capital Management Company, LLC 543,715$2,267,0000.16%
HighTower Advisors, LLC 2,355,942$9,826,0000.08%
Granite Investment Partners, LLC 215,760$900,0000.06%
WRAPMANAGER INC 39,547$165,0000.05%
Alyeska Investment Group, L.P. 1,563,881$6,521,0000.05%
View complete list of GENMARK DIAGNOSTICS INC shareholders